Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
QuintilesIMS
Colorcon
Deloitte
Covington

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 8,853,380

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,853,380
Title:Modified SAK gene for the production of recombinant proteins
Abstract: The present invention relates to modified SAK gene having amino acid SEQ ID 2. The present invention further relates to process for cloning and expressing modified SAK gene fusion protein which imparts improved stability to the heterologous protein of interest. Further the invention relates to process of purification of recombinant heterologous proteins from bacterial inclusion bodies using modified SAK.
Inventor(s): Salunkhe; Shardul (Maharashtra, IN), Prasad; Bhaskarjyoti (Maharashtra, IN), Muneshwar; Praveen (Maharashtra, IN), Deshpande; Anjali Apte (Maharashtra, IN), Padmanabhan; Sriram (Maharashtra, IN)
Assignee: Lupin Limited (Mumbai, Maharashtra, IN)
Application Number:13/702,028
Patent Claims:see list of patent claims

Details for Patent 8,853,380

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Try a Free Trial Lupin Limited (Mumbai, Maharashtra, IN) 2030-06-04 RX search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23   Try a Free Trial Lupin Limited (Mumbai, Maharashtra, IN) 2030-06-04 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23   Try a Free Trial Lupin Limited (Mumbai, Maharashtra, IN) 2030-06-04 RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23   Try a Free Trial Lupin Limited (Mumbai, Maharashtra, IN) 2030-06-04 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKesson
Fish and Richardson
Cantor Fitzgerald
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.